GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Makers Laboratories Ltd (BOM:506919) » Definitions » EV-to-EBITDA

Makers Laboratories (BOM:506919) EV-to-EBITDA : 7.72 (As of May. 25, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Makers Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Makers Laboratories's enterprise value is ₹1,357 Mil. Makers Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was ₹176 Mil. Therefore, Makers Laboratories's EV-to-EBITDA for today is 7.72.

The historical rank and industry rank for Makers Laboratories's EV-to-EBITDA or its related term are showing as below:

BOM:506919' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.75   Med: 7.58   Max: 55.46
Current: 7.72

During the past 13 years, the highest EV-to-EBITDA of Makers Laboratories was 55.46. The lowest was 3.75. And the median was 7.58.

BOM:506919's EV-to-EBITDA is ranked better than
72.65% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.73 vs BOM:506919: 7.72

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-25), Makers Laboratories's stock price is ₹159.30. Makers Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹10.590. Therefore, Makers Laboratories's PE Ratio (TTM) for today is 15.04.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Makers Laboratories EV-to-EBITDA Historical Data

The historical data trend for Makers Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Makers Laboratories EV-to-EBITDA Chart

Makers Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.13 17.79 6.52 19.47 47.39

Makers Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.59 47.39 20.22 8.24 6.05

Competitive Comparison of Makers Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Makers Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Makers Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Makers Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Makers Laboratories's EV-to-EBITDA falls into.


;
;

Makers Laboratories EV-to-EBITDA Calculation

Makers Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1357.179/175.823
=7.72

Makers Laboratories's current Enterprise Value is ₹1,357 Mil.
Makers Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹176 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Makers Laboratories  (BOM:506919) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Makers Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=159.30/10.590
=15.04

Makers Laboratories's share price for today is ₹159.30.
Makers Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹10.590.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Makers Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Makers Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Makers Laboratories Business Description

Traded in Other Exchanges
N/A
Address
54-D, Kandivli Industrial Estate, Charkop, Kandivali (West), Mumbai, MH, IND, 400067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti cough Range), and Exylin (Amoxycillin range) among others. It has two reportable segments; Pharmaceutical and Chemical Manufacturing. Maximum revenue is generated from its Chemical Manufacturing segment.

Makers Laboratories Headlines

No Headlines